Sign Up to like & get
recommendations!
0
Published in 2020 at "Clinical Neurology and Neurosurgery"
DOI: 10.1016/j.clineuro.2020.105781
Abstract: OBJECTIVES To understand the prognostic value of laboratory markers at presentation on post-treatment survival of patients 50 and older following cervical spine fracture. PATIENTS AND METHODS We obtained clinical data on patients 50 and older…
read more here.
Keywords:
cervical spine;
prognostic value;
mortality;
value laboratory ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.1290
Abstract: Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA) and rheumatoid arthritis (RA). In most countries where tofacitinib is approved, 5 mg twice daily (BID) is the recommended dose…
read more here.
Keywords:
tofacitinib bid;
pfizer inc;
laboratory values;
pfizer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2022-324192
Abstract: Objective To develop predictive models of Ureaplasma spp lower airway tract infection in preterm infants. Methods A dataset was assembled from five cohorts of infants born 72 hours were significant predictors in all 3 models.…
read more here.
Keywords:
laboratory values;
infection;
ureaplasma infection;
likelihood lower ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of neurosurgery"
DOI: 10.3171/2021.8.jns211509
Abstract: OBJECTIVE The incidence of hemorrhage in patients who undergo deep brain stimulation (DBS) and spinal cord stimulation (SCS) is between 0.5% and 2.5%. Coagulation status is one of the factors that can predispose patients to…
read more here.
Keywords:
coagulation status;
laboratory values;
coagulation;
antiplatelet medications ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.778380
Abstract: Introduction For squamous cell carcinoma of the head and neck (HNSCC), cisplatin is used as primary or adjuvant (radio)chemotherapy. In terms of dosage, two main regimens are used, weekly 40mg/m2 or 3-weekly 100mg/m2. For an…
read more here.
Keywords:
total dose;
cisplatin;
laboratory values;
cumulative total ... See more keywords